SEC Filings
State Street Reports 4.1% Ironwood Stake As Drugmaker Raises Its Annual Revenue Outlook
The holding dates to September 30, and State Street certified it was not seeking to influence the drugmaker's control.
Ironwood Pharmaceuticals (IRWD) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
The holding dates to September 30, and State Street certified it was not seeking to influence the drugmaker's control.
SEC Filings
The drugmaker lifted its annual outlook for a second consecutive quarter while operating cash flow reached $130.8 million.